International Forum for the Advancement of Diabetes Research and Care, April 29-30, 2011, Athens, Greece
The International Forum for the Advancement of Diabetes Research and Care brought together distinguished international experts in diabetes to discuss diverse trends and emerging issues in diabetes therapy and management. The plenary sessions on the first day focused on trends in insulin therapy, the...
Gespeichert in:
Veröffentlicht in: | Diabetes technology & therapeutics 2011-09, Vol.13 (9), p.967-979 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 979 |
---|---|
container_issue | 9 |
container_start_page | 967 |
container_title | Diabetes technology & therapeutics |
container_volume | 13 |
creator | Bolli, Geremia B Deeb, Larry C Garg, Satish K Leahy, John L Mazze, Roger S Owens, David R Riddle, Matthew C Southerland, Phil Strock, Ellie S |
description | The International Forum for the Advancement of Diabetes Research and Care brought together distinguished international experts in diabetes to discuss diverse trends and emerging issues in diabetes therapy and management. The plenary sessions on the first day focused on trends in insulin therapy, the role of glucagon-like peptide-1 receptor agonists in diabetes treatment, the relationship between diabetes and cardiovascular risk, and the challenges associated with the development of clinically relevant treatment guidelines. Interactive breakout sessions addressed the following topics: microvascular complications of diabetes; the need for a team approach to patient education; optimal management of Asian people with diabetes; the role of continuous glucose monitoring in assessing glucose variability; and lessons learned from biosimilar drugs. The plenary sessions on the second day covered self-monitoring of blood glucose, treatment and prevention of type 1 diabetes, and future directions for diabetes therapy. The meeting represented an excellent forum for the presentation of new research and the exchange of ideas aimed at improving outcomes for people with diabetes. |
doi_str_mv | 10.1089/dia.2011.0179 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3160268</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A267811221</galeid><sourcerecordid>A267811221</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3689-7a08d58feec5f1ca488e998b52a22aeea9ccb4e13c1cf716daf03474a1e9c1413</originalsourceid><addsrcrecordid>eNptkcFrFDEUxgdRbK0evUrAg5edNS8zmUkuwrLaWigIoufwNvPSjcwkNZkt9L83w7alBZNDHi-_9_ElX1W9B74GrvTnweNacIA1h16_qE5Byr5WUjcvl1rwWoPsTqo3Of_hnPeNgNfViQDVtVy3p9X-MsyUAs4-BhzZeUyHibmY2LwnthluMViaKMwsOvbV445myuwnZcJk9wzDwLaYaMU2N8mPTOi64Su2-CmtIhHyil0kIktvq1cOx0zv7s-z6vf5t1_b7_XVj4vL7eaqtk2ndN0jV4NUroxIBxZbpUhrtZMChUAi1NbuWoLGgnU9dAM63rR9i0DaQgvNWfXlqHtz2E002OI94WiKvQnTnYnozfOb4PfmOt6aBjouOlUEPt0LpPj3QHk2k8-WxhEDxUM2SkkpdVmF_Hgkr3Ek44OLRdAutNmIrlcAQiyG1v-hyh5o8jYGcr70nw3UxwGbYs6J3KN54GbJ3JTMzfLHZsm88B-evviRfgi5-QcnraVC</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>885559999</pqid></control><display><type>article</type><title>International Forum for the Advancement of Diabetes Research and Care, April 29-30, 2011, Athens, Greece</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Bolli, Geremia B ; Deeb, Larry C ; Garg, Satish K ; Leahy, John L ; Mazze, Roger S ; Owens, David R ; Riddle, Matthew C ; Southerland, Phil ; Strock, Ellie S</creator><creatorcontrib>Bolli, Geremia B ; Deeb, Larry C ; Garg, Satish K ; Leahy, John L ; Mazze, Roger S ; Owens, David R ; Riddle, Matthew C ; Southerland, Phil ; Strock, Ellie S</creatorcontrib><description>The International Forum for the Advancement of Diabetes Research and Care brought together distinguished international experts in diabetes to discuss diverse trends and emerging issues in diabetes therapy and management. The plenary sessions on the first day focused on trends in insulin therapy, the role of glucagon-like peptide-1 receptor agonists in diabetes treatment, the relationship between diabetes and cardiovascular risk, and the challenges associated with the development of clinically relevant treatment guidelines. Interactive breakout sessions addressed the following topics: microvascular complications of diabetes; the need for a team approach to patient education; optimal management of Asian people with diabetes; the role of continuous glucose monitoring in assessing glucose variability; and lessons learned from biosimilar drugs. The plenary sessions on the second day covered self-monitoring of blood glucose, treatment and prevention of type 1 diabetes, and future directions for diabetes therapy. The meeting represented an excellent forum for the presentation of new research and the exchange of ideas aimed at improving outcomes for people with diabetes.</description><identifier>ISSN: 1520-9156</identifier><identifier>EISSN: 1557-8593</identifier><identifier>DOI: 10.1089/dia.2011.0179</identifier><identifier>PMID: 21864094</identifier><language>eng</language><publisher>United States: Mary Ann Liebert, Inc</publisher><subject>Animals ; Biomedical Research ; Blood Glucose Self-Monitoring - methods ; Diabetes Complications - metabolism ; Diabetes Complications - physiopathology ; Diabetes Complications - prevention & control ; Diabetes Complications - therapy ; Diabetes Mellitus - blood ; Diabetes Mellitus - metabolism ; Diabetes Mellitus - physiopathology ; Diabetes Mellitus - therapy ; Female ; Humans ; Hypoglycemic Agents - therapeutic use ; Male ; Meeting Report ; Monitoring, Ambulatory ; Patient Education as Topic ; Pregnancy ; Pregnancy in Diabetics - blood ; Pregnancy in Diabetics - therapy</subject><ispartof>Diabetes technology & therapeutics, 2011-09, Vol.13 (9), p.967-979</ispartof><rights>COPYRIGHT 2011 Mary Ann Liebert, Inc.</rights><rights>Copyright 2011, Mary Ann Liebert, Inc. 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3689-7a08d58feec5f1ca488e998b52a22aeea9ccb4e13c1cf716daf03474a1e9c1413</citedby><cites>FETCH-LOGICAL-c3689-7a08d58feec5f1ca488e998b52a22aeea9ccb4e13c1cf716daf03474a1e9c1413</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,309,310,314,776,780,785,786,881,23910,23911,25119,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21864094$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bolli, Geremia B</creatorcontrib><creatorcontrib>Deeb, Larry C</creatorcontrib><creatorcontrib>Garg, Satish K</creatorcontrib><creatorcontrib>Leahy, John L</creatorcontrib><creatorcontrib>Mazze, Roger S</creatorcontrib><creatorcontrib>Owens, David R</creatorcontrib><creatorcontrib>Riddle, Matthew C</creatorcontrib><creatorcontrib>Southerland, Phil</creatorcontrib><creatorcontrib>Strock, Ellie S</creatorcontrib><title>International Forum for the Advancement of Diabetes Research and Care, April 29-30, 2011, Athens, Greece</title><title>Diabetes technology & therapeutics</title><addtitle>Diabetes Technol Ther</addtitle><description>The International Forum for the Advancement of Diabetes Research and Care brought together distinguished international experts in diabetes to discuss diverse trends and emerging issues in diabetes therapy and management. The plenary sessions on the first day focused on trends in insulin therapy, the role of glucagon-like peptide-1 receptor agonists in diabetes treatment, the relationship between diabetes and cardiovascular risk, and the challenges associated with the development of clinically relevant treatment guidelines. Interactive breakout sessions addressed the following topics: microvascular complications of diabetes; the need for a team approach to patient education; optimal management of Asian people with diabetes; the role of continuous glucose monitoring in assessing glucose variability; and lessons learned from biosimilar drugs. The plenary sessions on the second day covered self-monitoring of blood glucose, treatment and prevention of type 1 diabetes, and future directions for diabetes therapy. The meeting represented an excellent forum for the presentation of new research and the exchange of ideas aimed at improving outcomes for people with diabetes.</description><subject>Animals</subject><subject>Biomedical Research</subject><subject>Blood Glucose Self-Monitoring - methods</subject><subject>Diabetes Complications - metabolism</subject><subject>Diabetes Complications - physiopathology</subject><subject>Diabetes Complications - prevention & control</subject><subject>Diabetes Complications - therapy</subject><subject>Diabetes Mellitus - blood</subject><subject>Diabetes Mellitus - metabolism</subject><subject>Diabetes Mellitus - physiopathology</subject><subject>Diabetes Mellitus - therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>Male</subject><subject>Meeting Report</subject><subject>Monitoring, Ambulatory</subject><subject>Patient Education as Topic</subject><subject>Pregnancy</subject><subject>Pregnancy in Diabetics - blood</subject><subject>Pregnancy in Diabetics - therapy</subject><issn>1520-9156</issn><issn>1557-8593</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkcFrFDEUxgdRbK0evUrAg5edNS8zmUkuwrLaWigIoufwNvPSjcwkNZkt9L83w7alBZNDHi-_9_ElX1W9B74GrvTnweNacIA1h16_qE5Byr5WUjcvl1rwWoPsTqo3Of_hnPeNgNfViQDVtVy3p9X-MsyUAs4-BhzZeUyHibmY2LwnthluMViaKMwsOvbV445myuwnZcJk9wzDwLaYaMU2N8mPTOi64Su2-CmtIhHyil0kIktvq1cOx0zv7s-z6vf5t1_b7_XVj4vL7eaqtk2ndN0jV4NUroxIBxZbpUhrtZMChUAi1NbuWoLGgnU9dAM63rR9i0DaQgvNWfXlqHtz2E002OI94WiKvQnTnYnozfOb4PfmOt6aBjouOlUEPt0LpPj3QHk2k8-WxhEDxUM2SkkpdVmF_Hgkr3Ek44OLRdAutNmIrlcAQiyG1v-hyh5o8jYGcr70nw3UxwGbYs6J3KN54GbJ3JTMzfLHZsm88B-evviRfgi5-QcnraVC</recordid><startdate>201109</startdate><enddate>201109</enddate><creator>Bolli, Geremia B</creator><creator>Deeb, Larry C</creator><creator>Garg, Satish K</creator><creator>Leahy, John L</creator><creator>Mazze, Roger S</creator><creator>Owens, David R</creator><creator>Riddle, Matthew C</creator><creator>Southerland, Phil</creator><creator>Strock, Ellie S</creator><general>Mary Ann Liebert, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201109</creationdate><title>International Forum for the Advancement of Diabetes Research and Care, April 29-30, 2011, Athens, Greece</title><author>Bolli, Geremia B ; Deeb, Larry C ; Garg, Satish K ; Leahy, John L ; Mazze, Roger S ; Owens, David R ; Riddle, Matthew C ; Southerland, Phil ; Strock, Ellie S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3689-7a08d58feec5f1ca488e998b52a22aeea9ccb4e13c1cf716daf03474a1e9c1413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Animals</topic><topic>Biomedical Research</topic><topic>Blood Glucose Self-Monitoring - methods</topic><topic>Diabetes Complications - metabolism</topic><topic>Diabetes Complications - physiopathology</topic><topic>Diabetes Complications - prevention & control</topic><topic>Diabetes Complications - therapy</topic><topic>Diabetes Mellitus - blood</topic><topic>Diabetes Mellitus - metabolism</topic><topic>Diabetes Mellitus - physiopathology</topic><topic>Diabetes Mellitus - therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>Male</topic><topic>Meeting Report</topic><topic>Monitoring, Ambulatory</topic><topic>Patient Education as Topic</topic><topic>Pregnancy</topic><topic>Pregnancy in Diabetics - blood</topic><topic>Pregnancy in Diabetics - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bolli, Geremia B</creatorcontrib><creatorcontrib>Deeb, Larry C</creatorcontrib><creatorcontrib>Garg, Satish K</creatorcontrib><creatorcontrib>Leahy, John L</creatorcontrib><creatorcontrib>Mazze, Roger S</creatorcontrib><creatorcontrib>Owens, David R</creatorcontrib><creatorcontrib>Riddle, Matthew C</creatorcontrib><creatorcontrib>Southerland, Phil</creatorcontrib><creatorcontrib>Strock, Ellie S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Diabetes technology & therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bolli, Geremia B</au><au>Deeb, Larry C</au><au>Garg, Satish K</au><au>Leahy, John L</au><au>Mazze, Roger S</au><au>Owens, David R</au><au>Riddle, Matthew C</au><au>Southerland, Phil</au><au>Strock, Ellie S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>International Forum for the Advancement of Diabetes Research and Care, April 29-30, 2011, Athens, Greece</atitle><jtitle>Diabetes technology & therapeutics</jtitle><addtitle>Diabetes Technol Ther</addtitle><date>2011-09</date><risdate>2011</risdate><volume>13</volume><issue>9</issue><spage>967</spage><epage>979</epage><pages>967-979</pages><issn>1520-9156</issn><eissn>1557-8593</eissn><abstract>The International Forum for the Advancement of Diabetes Research and Care brought together distinguished international experts in diabetes to discuss diverse trends and emerging issues in diabetes therapy and management. The plenary sessions on the first day focused on trends in insulin therapy, the role of glucagon-like peptide-1 receptor agonists in diabetes treatment, the relationship between diabetes and cardiovascular risk, and the challenges associated with the development of clinically relevant treatment guidelines. Interactive breakout sessions addressed the following topics: microvascular complications of diabetes; the need for a team approach to patient education; optimal management of Asian people with diabetes; the role of continuous glucose monitoring in assessing glucose variability; and lessons learned from biosimilar drugs. The plenary sessions on the second day covered self-monitoring of blood glucose, treatment and prevention of type 1 diabetes, and future directions for diabetes therapy. The meeting represented an excellent forum for the presentation of new research and the exchange of ideas aimed at improving outcomes for people with diabetes.</abstract><cop>United States</cop><pub>Mary Ann Liebert, Inc</pub><pmid>21864094</pmid><doi>10.1089/dia.2011.0179</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1520-9156 |
ispartof | Diabetes technology & therapeutics, 2011-09, Vol.13 (9), p.967-979 |
issn | 1520-9156 1557-8593 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3160268 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Animals Biomedical Research Blood Glucose Self-Monitoring - methods Diabetes Complications - metabolism Diabetes Complications - physiopathology Diabetes Complications - prevention & control Diabetes Complications - therapy Diabetes Mellitus - blood Diabetes Mellitus - metabolism Diabetes Mellitus - physiopathology Diabetes Mellitus - therapy Female Humans Hypoglycemic Agents - therapeutic use Male Meeting Report Monitoring, Ambulatory Patient Education as Topic Pregnancy Pregnancy in Diabetics - blood Pregnancy in Diabetics - therapy |
title | International Forum for the Advancement of Diabetes Research and Care, April 29-30, 2011, Athens, Greece |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T01%3A07%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=International%20Forum%20for%20the%20Advancement%20of%20Diabetes%20Research%20and%20Care,%20April%2029-30,%202011,%20Athens,%20Greece&rft.jtitle=Diabetes%20technology%20&%20therapeutics&rft.au=Bolli,%20Geremia%20B&rft.date=2011-09&rft.volume=13&rft.issue=9&rft.spage=967&rft.epage=979&rft.pages=967-979&rft.issn=1520-9156&rft.eissn=1557-8593&rft_id=info:doi/10.1089/dia.2011.0179&rft_dat=%3Cgale_pubme%3EA267811221%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=885559999&rft_id=info:pmid/21864094&rft_galeid=A267811221&rfr_iscdi=true |